Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Leptomeningeal Metastasis|Leptomeningeal Disease
Interventions: RADIATION: Radiation Therapy|DRUG: Pertuzumab|DRUG: Trastuzumab
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Genentech, Inc.